B. Gregory

526 total citations
9 papers, 431 citations indexed

About

B. Gregory is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, B. Gregory has authored 9 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in B. Gregory's work include Single-cell and spatial transcriptomics (2 papers), Cancer Genomics and Diagnostics (2 papers) and CRISPR and Genetic Engineering (1 paper). B. Gregory is often cited by papers focused on Single-cell and spatial transcriptomics (2 papers), Cancer Genomics and Diagnostics (2 papers) and CRISPR and Genetic Engineering (1 paper). B. Gregory collaborates with scholars based in United States. B. Gregory's co-authors include Astrid Layton, T.W. Schultz, Gary S. Sayler, Julie R. Seward, M Cronin, T. Wayne Schultz, David H. Buss, J. Galleshaw, Timothy E. Kute and Douglas Case and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and Blood.

In The Last Decade

B. Gregory

8 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Gregory United States 6 210 193 66 60 53 9 431
Keke Ding China 7 112 0.5× 156 0.8× 31 0.5× 141 2.4× 11 0.2× 10 415
G. Luthe Netherlands 12 57 0.3× 215 1.1× 23 0.3× 50 0.8× 52 1.0× 29 417
Chuan-Hai Li China 12 95 0.5× 570 3.0× 37 0.6× 118 2.0× 41 0.8× 15 780
Tatsushi Shiozawa Japan 14 352 1.7× 491 2.5× 11 0.2× 146 2.4× 151 2.8× 20 750
Weiping Qin China 11 135 0.6× 361 1.9× 25 0.4× 76 1.3× 22 0.4× 13 612
Jui-Hua Hsieh United States 6 73 0.3× 181 0.9× 88 1.3× 104 1.7× 14 0.3× 6 340
Weiling Xue United States 7 211 1.0× 431 2.2× 20 0.3× 293 4.9× 302 5.7× 13 880
Tuula Thunberg Sweden 9 74 0.4× 246 1.3× 10 0.2× 149 2.5× 119 2.2× 11 568
Alexander Böhme Germany 13 64 0.3× 205 1.1× 59 0.9× 101 1.7× 30 0.6× 27 559
Katarzyna Skupińska Poland 10 50 0.2× 110 0.6× 17 0.3× 209 3.5× 37 0.7× 13 389

Countries citing papers authored by B. Gregory

Since Specialization
Citations

This map shows the geographic impact of B. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Gregory more than expected).

Fields of papers citing papers by B. Gregory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Gregory. The network helps show where B. Gregory may publish in the future.

Co-authorship network of co-authors of B. Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of B. Gregory. A scholar is included among the top collaborators of B. Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Gregory. B. Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tagmount, Abderrahmane, B. Gregory, Xueyuan Cao, et al.. (2023). CRISPR/Cas9 Screen Identifies CPX-351 and 7+3 Regimens Response Modulators with Distinct Sensitive and Resistant Profiles. Blood. 142(Supplement 1). 1412–1412.
2.
Pusztai, L., B. Gregory, Francisco J. Esteva, et al.. (2004). Pharmacoproteomic analysis of pre-and post-chemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology. 22(14_suppl). 2109–2109. 6 indexed citations
3.
Layton, Astrid, B. Gregory, Julie R. Seward, T.W. Schultz, & Gary S. Sayler. (2000). Mineralization of Steroidal Hormones by Biosolids in Wastewater Treatment Systems in Tennessee U.S.A.. Environmental Science & Technology. 34(18). 3925–3931. 210 indexed citations
4.
Layton, Astrid, B. Gregory, T.W. Schultz, & Gary S. Sayler. (1999). Validation of Genetically Engineered Bioluminescent Surfactant Resistant Bacteria as Toxicity Assessment Tools. Ecotoxicology and Environmental Safety. 43(2). 222–228. 16 indexed citations
5.
Cronin, M, B. Gregory, & T. Wayne Schultz. (1998). Quantitative Structure−Activity Analyses of Nitrobenzene Toxicity to Tetrahymena pyriformis. Chemical Research in Toxicology. 11(8). 902–908. 121 indexed citations
6.
Powell, Bayard L., et al.. (1995). GM-CSF and asparaginase potentiate ara-C cytotoxicity in HL-60 cells.. PubMed. 9(3). 405–9. 4 indexed citations
7.
Kute, Timothy E., Hyman B. Muss, M. Robert Cooper, et al.. (1990). The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients. Cancer. 66(8). 1810–1816. 35 indexed citations
8.
Gregory, B., et al.. (1988). Buss D. Case D How reproducible are flow cytometry data from paraffin embedded blocks. 2 indexed citations
9.
Kute, Timothy E., et al.. (1988). How reproducible are flow cytometry data from paraffin‐embedded blocks?. Cytometry. 9(5). 494–498. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026